"A growing number of people - including military veterans and former professional athletes - have spoken out about the benefits they have experienced from using psychedelics to address mental health issues, including PTSD. While there are some anecdotal reports of this phenomenon, a number of researchers have also conducted studies on it - and that has led in turn to a growing amount of data on psychedelics' use in this field."
"You might be surprised to read that, given that the benefits of this therapy could have serious benefits for millions of people. In a recent article for Live Science, Jane Palmer pointed out one reason: ayahuasca has two significant ingredients that can vary dramatically. This, Palmer writes, poses a challenge: developing "a standardized, repeatable dose required for rigorous clinical trials.""
Ayahuasca and psilocybin therapies administered in communal settings reduce depression and PTSD symptoms among veterans. Psilocybin shows broader effectiveness across multiple mental health measures, while ayahuasca demonstrates particular strength against PTSD. Positive outcomes include improvements in mental well-being, quality of life, anxiety, sleep, concussion symptoms, and post-deployment reintegration. Variability in ayahuasca's two active ingredients complicates dose standardization and rigorous clinical trial design. Ongoing work includes using EEG measurements to assess ayahuasca's effects on the brain before and after retreat experiences. Improved objective measures may help expand access to effective psychedelic-assisted care for those in need.
Read at InsideHook
Unable to calculate read time
Collection
[
|
...
]